Literature DB >> 14578296

Counterregulatory hormone and symptom responses to insulin-induced hypoglycemia in the postprandial state in humans.

Francesca Porcellati1, Simone Pampanelli, Paolo Rossetti, Cristina Cordoni, Stefania Marzotti, Luciano Scionti, Geremia B Bolli, Carmine G Fanelli.   

Abstract

Plasma counterregulatory hormones and symptoms were measured during hypoglycemia in the postprandial and in the fasting state in humans to establish differences in physiological responses. We studied 8 nondiabetic subjects and 10 subjects with type 1 diabetes on two different occasions during clamped insulin-induced hypoglycemia (2.4 mmol/l) in the sitting position. On one occasion, subjects ate a standard mixed meal, and on the other they remained fasting. In response to postprandial as compared with fasting hypoglycemia, nondiabetic subjects exhibited lower total symptom scores (6.6 +/- 0.4 vs. 11.5 +/- 0.8, P = 0.001), which was due to less hunger (1.1 +/- 0.1 vs. 4.2 +/- 0.2), lower suppression of plasma C-peptide (0.23 +/- 0.1 vs. 0.08 +/- 0.07 nmol/l, P = 0.032), and greater responses of plasma glucagon (248 +/- 29 vs. 163 +/- 25 ng x l(-1) x min(-1), P = 0.018), plasma adrenaline (4.5 +/- 0.6 vs. 3.1 +/- 0.4 nmol x l(-1) x min(-1), P = 0.037), norepinephrine (3.8 +/- 0.3 vs. 3.2 +/- 0.2 nmol x l(-1) x min(-1), P = 0.037), and pancreatic polypeptide (217 +/- 12 vs. 159 +/- 22 pmol x l(-1) x min(-1), P = 0.08). Except for plasma C-peptide, responses in diabetic subjects were similarly affected. Notably, in diabetic subjects responses of glucagon, which were absent in the fasting state, nearly normalized after a meal. In conclusion, in the postprandial compared with the fasting hypoglycemic state, total symptoms are less, but counterregulatory hormones are greater and responses of glucagon nearly normalize in type 1 diabetic subjects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14578296     DOI: 10.2337/diabetes.52.11.2774

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  6 in total

1.  Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis.

Authors:  Moira L Aitken; Magdalena A Szkudlinska; Edward J Boyko; Debbie Ng; Kristina M Utzschneider; Steven E Kahn
Journal:  Diabetologia       Date:  2020-01-29       Impact factor: 10.122

2.  Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.

Authors:  F Porcellati; S Pampanelli; P Rossetti; N Busciantella Ricci; S Marzotti; P Lucidi; F Santeusanio; G B Bolli; C G Fanelli
Journal:  Diabetologia       Date:  2006-12-12       Impact factor: 10.122

Review 3.  Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.

Authors:  Robert L Rodgers
Journal:  Physiol Rep       Date:  2022-05

4.  The effects of hypo- and hyperglycaemia on the hypoxic ventilatory response in humans.

Authors:  Denham S Ward; William A Voter; Suzanne Karan
Journal:  J Physiol       Date:  2007-05-03       Impact factor: 5.182

5.  Y1 receptor deficiency in β-cells leads to increased adiposity and impaired glucose metabolism.

Authors:  Kim Loh; Yan-Chuan Shi; Mohammed Bensellam; Kailun Lee; D Ross Laybutt; Herbert Herzog
Journal:  Sci Rep       Date:  2018-09-03       Impact factor: 4.379

6.  Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.

Authors:  Paolo Rossetti; Francesca Porcellati; Natalia Busciantella Ricci; Paola Candeloro; Patrizia Cioli; K Sreekumaran Nair; Fausto Santeusanio; Geremia B Bolli; Carmine G Fanelli
Journal:  Diabetes       Date:  2008-04-04       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.